Feedback Share Discussion Threads

[lr2] 22/8/2022 14:16

Only 375k shares available on-line at 0.55p

[digger2779] 22/8/2022 13:30

Listened to the Sunday roast interview again and it does sound more than good. If only half of what he said comes to fruition then we would be grinning like a Cheshire cat.
So we wait and wait. In the meantime, parsnips anyone? You can have mine as I can't stand them.

[yump] 22/8/2022 10:20

I heard a rumour that there is a new book coming out on how to build a business using Twitter. The authors are a collection of AIM CEO's.

Oh sorry, I got the title wrong, its "how to justify your salary using Twitter".

[lr2] 21/8/2022 17:03

Hi Ged, it was good to see some buying on Friday. Let's hope it continues this week.

Perhaps putting a link to the Sunday Roast interview will help. Well worth a listen for anyone who hasn't heard it yet.

[ged5] 21/8/2022 15:08

I notice they talk about partners in your link in post 10096, LR2. Bleepa already have Qure.AI, Quest Teleradiology and of course Amazon.

Some interesting trades last week and a welcome rise on Friday. Long way to go to fulfill the potential described in the Sunday Roast interview by Tom Oakley.

[ducatiman] 19/8/2022 17:03

digger, not necessarily!

[digger2779] 19/8/2022 16:56

Going to need a hell of a lot of buying to get me into breakeven territory.

[ducatiman] 19/8/2022 16:21

Buying continued. The mkt in general seems a bit happier today.

[lr2] 19/8/2022 15:05

Top 15 Digital Health Data Services In 2022



15. Bleepa

Data & analytics application. A communication tool called Bleepa is intended for use by hospital workers. It combines the capacity to transmit clinical-grade medical photos with secure instant chat (e.g. x-rays). This implies that medical professionals spread around a hospital location can quickly evaluate photos, debate issues, and reach a consensus. There is always the issue of privacy with any communication platform, especially one that deals with private medical information. The hospital is in charge of managing the data because Bleepa is healthcare software. This is another health data services.

The NHSx Clinical Communication Tools Framework includes Bleepa. Communication solutions that save medical staff time and expedite patient care are essential in light of COVID-19 and the strain hospitals are under.

[lr2] 19/8/2022 08:46

Little bit of buying to start the day.

[lr2] 16/8/2022 22:37

Know the feeling Digger. These fuel bills are exorbitant. Costs more to cook a pizza than to buy one... and my son lives on them.

[digger2779] 16/8/2022 21:58

LR - not me guv. Am brassic at the mo.

[lr2] 16/8/2022 17:39

A couple of large trades from yesterday have shown up after the bell today, anyone here want to own up to them?

15-Aug-22 12:32:41 0.485p 15,787,022 Unknown* 0.47 0.50 76.57k O
15-Aug-22 12:32:36 0.485p 15,787,022 Unknown* 0.47 0.50 76.57k O

[lr2] 16/8/2022 16:30

Tom is anticipating £590k revenue for the first 6 months of the year and being as much of it is on a rolling contract I'd hope for at least £1.2 million for a full year even if next to nobody further takes up Bleepa / Carelocker.

Not quite staying at home with baby is it? Still it would be nice if the company could supply us with an update. How India is progressing would be good.

[lr2] 16/8/2022 12:08

Placing coming at IQAI if they can get one away otherwise Trevor will cover funds needed with loan notes at the best price he can get away with.

Edit at 13:35. Wow Trevor. IQAI now down 20% on results. Shouldn't you be posting your financial excuses on IQAI rather than being over here bothering the fine folk of Feedback?

[ducatiman] 16/8/2022 11:12

They won’t be making an offer then LR2? 😂

[lr2] 16/8/2022 10:22

Have you seen IQAI's half year results today Duc? Awful.

Disagreement with the FDA over classification of IB Zero G. That will slow progress.
Almost flat revenue.
Increased operating expenses. Admin up a lot.
Increased loss - Loss before tax for the period was £330,584 (2021: £207,135).
Foreign exchange loss of £125k.
Cash of only £354k - placing soon I suspect.
Current liabilities exceed cash in bank.

I could go on but I'm due at the dentist soon so that will have to be it for now.

"The current economic conditions continue to create uncertainty, particularly over (a) the level of demand for the group's products; and (b) the availability of finance for the foreseeable future. The group's forecasts and projections, taking account of reasonably possible changes in trading performance, show that additional funding will be required either via an issue of equity or through the issuance of convertible loan notes."

IQAI investors beware.

[ducatiman] 16/8/2022 09:04

£13m mkt cap, £9m cash. How’s your warchest fybberf? Texrad, Bleepa etc for £4m. Sounds cheap.

[ydderf] 16/8/2022 08:42

Strange but true. The price is back to the level I bought in at 9 years ago prior to doing the RTO of the two original operating companies - anyone remember Texrad?

[buywell3] 16/8/2022 00:52

Next chart support


free stock charts from uk.advfn.com

[buywell3] 16/8/2022 00:43

First chart low support got tested --- and failed




buywell3 18 Feb '22 - 20:42 - 9683 of 10081 Edit

Too much ramping on next to nothing sales imo

Reminds buywell of another share that was tipped for NHS bigtime take-up

Attracted a star fund manager at the time that bought a big holding --- and a potential USA partner

But the NHS never moved and the share price slid till it delisted


free stock charts from uk.advfn.com

[petekand] 15/8/2022 22:15

I see even Satan has given up today and sold all his shares in one go.

[ydderf] 15/8/2022 09:53

Yes ducatiman the Rupee appears to be finally dropping here....